Hjem › Spiserørkreft › Virginia › Arlington
Kliniske studier for Spiserørkreft i Arlington, VA
11 studier for Spiserørkreft søker deltakere på steder i og rundt Arlington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
- Inova Fair Oaks Hospital, Fairfax · 11 mi unna
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruttererFase 1
- Site 04, Fairfax · 11 mi unna
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RekruttererFase 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · 11 mi unna
- Inova Schar Cancer, Fairfax · 11 mi unna
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi unna
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruttererFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekruttererFase 3
- Research Site, Fairfax · 11 mi unna
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RekruttererFase 1
- NEXT Virginia, Fairfax · 11 mi unna
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Clinical Trial Site, Fairfax · 11 mi unna
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruttererFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekruttererFase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mi unna
Spiserørkreft-studier i andre byer
- Houston, TX36 studier
- Boston, MA23 studier
- New York City, NY22 studier
- Nashville, TN19 studier
- St. Louis, MO17 studier
- Pittsburgh, PA15 studier
- Los Angeles, CA15 studier
- Baldwin Park, CA14 studier
- Grand Rapids, MI14 studier
- Philadelphia, PA13 studier
- San Antonio, TX12 studier
- Rochester, MN11 studier
Andre studier i Arlington
- Ikke-småcellet lungekreft104 studier
- Metastatisk kreft53 studier
- Kolorektal kreft52 studier
- Kreft (alle typer)48 studier
- Brystkreft47 studier
- Eggstokkreft46 studier
- Lungekreft41 studier
- Endometriekreft39 studier
- Pankreaskreft33 studier
- Plateepitelcancer i hode og hals26 studier
- Småcellet lungekreft23 studier
- Mavekreft20 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.